Volume 9 Issue 7
Jul.  2018
Turn off MathJax
Article Contents
Haili Ma, Siye Chen, Yan He, Jingwei Huang, Yanhong Xu, Chao Wang, Cheng Lei, Ting Lu, Shengdong Xiao, Jinming Mao, Yiyun Xu, Hao Guo, Bohua Li, Minghui Zhang, Xiaowen He. Redirecting T cells to glypican-3 with 28.41BB.ζ and 28.ζ-41BBL CARs for hepatocellular carcinoma treatment[J]. Protein&Cell, 2018, 9(7): 664-669. doi: 10.1007/s13238-017-0489-0
Citation: Haili Ma, Siye Chen, Yan He, Jingwei Huang, Yanhong Xu, Chao Wang, Cheng Lei, Ting Lu, Shengdong Xiao, Jinming Mao, Yiyun Xu, Hao Guo, Bohua Li, Minghui Zhang, Xiaowen He. Redirecting T cells to glypican-3 with 28.41BB.ζ and 28.ζ-41BBL CARs for hepatocellular carcinoma treatment[J]. Protein&Cell, 2018, 9(7): 664-669. doi: 10.1007/s13238-017-0489-0

Redirecting T cells to glypican-3 with 28.41BB.ζ and 28.ζ-41BBL CARs for hepatocellular carcinoma treatment

doi: 10.1007/s13238-017-0489-0
  • loading
  • [1]
    Ahmed N, Brawley VS, Hegde M et al (2015) Human Epidermal Growth Factor Receptor 2 (HER2)-Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma. J Clin Oncol 33(15):1688-1696
    [2]
    Dredge K, Marriott JB, Todryk SM, Dalgleish AG (2015) Adjuvants and the promotion of Th1-type cytokines in tumour immunotherapy. Cancer Immunol Immunother 51(10):521-531
    [3]
    Gao H, Li K, Tu H et al (2014) Development of T cells redirected to glypican-3 for the treatment of hepatocellular carcinoma. Clin Cancer Res 20(24):6418-6428
    [4]
    Gilham DE, Debets R, Pule M, Hawkins RE, Abken H (2012) CAR-T cells and solid tumors:tuning T cells to challenge an inveterate foe. Trends Mol Med 18(7):377-384
    [5]
    Grupp SA, Kalos M, Barrett D et al (2013) Chimeric antigen receptormodified T cells for acute lymphoid leukemia. N Engl J Med 368(16):1509-1518
    [6]
    Kalos M, Levine BL, Porter DL et al (2011) Tcells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia. Sci Transl Med 3(95):95ra73
    [7]
    Kohler BA, Sherman RL, Howlader N, et al. (2015) Annual Report to the Nation on the Status of Cancer, 1975-2011, featuring incidence of breast cancer subtypes by race/ethnicity, poverty, and state. J Natl Cancer Inst107(6)
    [8]
    Li W, Guo L, Rathi P, Marinova E, Gao X, Wu MF, Liu H, Dotti G, Gottschalk S,Metelitsa LS,Heczey A (2016) Redirecting T Cells toGlypican-3 with 4-1BB Zeta Chimeric Antigen Receptors Results in Th1 Polarization and Potent Antitumor Activity. Hum Gene Ther 2016 Aug 16
    [9]
    Mannino MH, Zhu Z, Xiao H, Bai Q, Wakefield MR, Fang Y (2015) The paradoxical role of IL-10 in immunity and cancer. Cancer Lett 367(2):103-107
    [10]
    Maude SL, Frey N, Shaw PA et al (2014) Chimeric antigen receptor T cells for sustained remissions in leukemia. N Engl J Med 371(16):1507-1517
    [11]
    Pule MA, Savoldo B, Myers GD et al (2008) Virus-specific T cells engineered to coexpress tumor-specific receptors:persistence andantitumor activity in individuals with neuroblastoma. Nat Med 14(11):1264-1270
    [12]
    Sato T, Terai M, Tamura Y, Alexeev V, Mastrangelo M, Selvan S (2011) Interleukin 10 in the tumor microenvironment:a target for anticancer immunotherapy. Immunol Res 51(2-3):170-182
    [13]
    Taub DD, Anver M, Oppenheim JJ, Longo DL, Murphy WJ (1996) T lymphocyte recruitment by interleukin-8 (IL-8). IL-8-induced degranulation of neutrophils releases potent chemoattractants for human T lymphocytes both in vitro and in vivo. J Clin Invest 97(8):1931-1941
    [14]
    Zhao Zeguo, Condomines Maud, van der Stegen Sjoukje JC, Perna Fabiana, Kloss Christopher C, Gunset Gertrude, Plotkin Jason, Sadelain Michel (2015) Structural Design of Engineered Costimulation Determines Tumor Rejection Kinetics and Persistence of CAR T Cells. Cancer Cell 28:415-428
    [15]
    Zhu AX, Gold PJ, El-Khoueiry AB et al (2013) First-in-man phase I study of GC33, a novel recombinant humanized antibody against glypican-3, in patients with advanced hepatocellular carcinoma. Electronic supplementary material The online version of this Clin Cancer Res 19(4):920-928
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (66) PDF downloads(1000) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return